Le Rhun E, Taillibert S, Chamberlain MC. Carcinomatous meningitis: leptomeningeal metastases in solid tumors. Surg Neurol Int. 2013;4:S265.
Article PubMed PubMed Central Google Scholar
Bander ED, et al. Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies. Cancer. 2021;127:2062–73.
Article CAS PubMed Google Scholar
Cagney DN, et al. Implications of screening for brain metastases in patients with breast cancer and non-small cell lung cancer. JAMA Oncol. 2018;4:1001–3.
Article PubMed PubMed Central Google Scholar
Seute T, Leffers P, ten Velde GP, Twijnstra A. Leptomeningeal metastases from small cell lung carcinoma. Cancer. 2005;104:1700–5.
Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM. Leptomeningeal metastases in the MRI era. Neurology. 2010;74:1449–54.
Article CAS PubMed PubMed Central Google Scholar
Abouharb S, et al. Leptomeningeal disease and breast cancer: the importance of tumor subtype. Breast Cancer Res Treat. 2014;146:477–86.
Article CAS PubMed Google Scholar
Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev. 1999;25:103–19.
Article CAS PubMed Google Scholar
•• Park S, et al. A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy. Ann Oncol. 2020;31:1397–404. This phase 2 continuation of the BLOOM study included a LM cohort of 17 patients and further supported activity of osimertinib in LM due to EGFRm NSCLC. Although this was a single-arm study, PFS and OS in the LM cohort were significantly improved compared to historical controls despite prior treatment with other EGFR-TKIs.
Article CAS PubMed Google Scholar
Engelhard HH, & Corsten LA. Leptomeningeal metastasis of primary central nervous system (CNS) neoplasms. Leptomeningeal Metastases. 2005;71–85
Prabhu RS, et al. A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases. Neuro Oncol. 2019;21:1049–59.
Article PubMed PubMed Central Google Scholar
Takeda H, et al. Rapid progression of intracranial dural metastases in a patient with carcinoma of unknown primary site. Case Reports in Oncology. 2019;12:666–70.
Article PubMed PubMed Central Google Scholar
Sullivan L, Smee R. Leptomeningeal carcinomatosis from perineural invasion of a lip squamous cell carcinoma. Australas Radiol. 2006;50:262–6.
Article CAS PubMed Google Scholar
Garzia L, et al. A hematogenous route for medulloblastoma leptomeningeal metastases. Cell. 2018;172:1050-1062 e1014.
Article CAS PubMed PubMed Central Google Scholar
Cordone I, et al. Major differences in lymphocyte subpopulations between cerebrospinal fluid and peripheral blood in non-Hodgkin lymphoma without leptomeningeal involvement: flow cytometry evidence of a cerebral lymphatic system. Front Oncol. 2021;11:685786.
Article PubMed PubMed Central Google Scholar
Thakkar JP, Kumthekar P, Dixit KS, Stupp R, Lukas RV. Leptomeningeal metastasis from solid tumors. J Neurol Sci. 2020;411:116706.
Nayar G, et al. Leptomeningeal disease: current diagnostic and therapeutic strategies. Oncotarget. 2017;8:73312.
Article PubMed PubMed Central Google Scholar
Remsik J, et al. Leptomeningeal metastatic cells adopt two phenotypic states. Cancer Reports. 2022;5:e1236.
Article CAS PubMed Google Scholar
Li YS, et al. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy. Ann Oncol. 2018;29:945–52.
Article CAS PubMed Google Scholar
Friedberg MH, Glantz MJ, Klempner MS, Cole BF, Perides G. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer: Interdiscip Int J Am Cancer Soc. 1998;82:923–30.
Groves MD, et al. Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma. J Neurooncol. 2009;94:229–34.
Article CAS PubMed Google Scholar
Stockhammer G, et al. Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis. Neurology. 2000;54:1670–6.
Article CAS PubMed Google Scholar
Boire A, et al. Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis. Cell. 2017;168:1101-1113 e1113.
Article CAS PubMed PubMed Central Google Scholar
•• Chi Y, et al. Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis. Science. 2020;369:276–82. Presents a novel mechanism by which LM cells both evade immune surveillance and survive in a nutrient-poor compartment. This is also the basis for an ongoing prospective clinical trial.
Article CAS PubMed PubMed Central Google Scholar
Bhambhvani HP, Rodrigues AJ, Umeh-Garcia MC, Gephart MH. Leptomeningeal carcinomatosis: Molecular landscape, current management, and emerging therapies. Neurosurg Clin. 2020;31:613–25.
Bhambhvani HP, Rodrigues AJ, Umeh-Garcia MC, Hayden Gephart M. Leptomeningeal carcinomatosis: molecular landscape, current management, and emerging therapies. Neurosurg Clin N Am. 2020;31:613–25.
Article PubMed PubMed Central Google Scholar
Baumgartner A, et al. Novel insights into diagnosis, biology, and treatment of primary diffuse leptomeningeal melanomatosis. J Personal Med. 2021;11:292.
Arai S, et al. Osimertinib overcomes alectinib resistance caused by amphiregulin in a leptomeningeal carcinomatosis model of ALK-rearranged lung cancer. J Thorac Oncol. 2020;15:752–65.
Article CAS PubMed Google Scholar
Pan, S., et al. Leptomeningeal disease and tumor in a murine DIPG model: implications for study of the tumor-CSF-ependymal microenvironment. Neuro-Oncology Advances (2022)
Glitza IC, et al. Leptomeningeal disease in melanoma patients: an update to treatment, challenges, and future directions. Pigment Cell Melanoma Res. 2020;33:527–41.
Article PubMed PubMed Central Google Scholar
Lamba N, Wen PY, Aizer AA. Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol. 2021;23:1447–56.
Article PubMed PubMed Central Google Scholar
Gold C, et al. Electrographic correlates of plateau waves in patients with leptomeningeal metastases. The Neurohospitalist. 2016;6:161–6.
Article CAS PubMed PubMed Central Google Scholar
Guo J-W, et al. Leptomeningeal carcinomatosis as the initial manifestation of gastric adenocarcinoma: a case report. World J Gastroenterol: WJG. 2014;20:2120.
Article PubMed PubMed Central Google Scholar
Damaske M, Panarese V, Casey S, Feeney M & Liuzzi FJ. Leptomeningeal carcinomatosis secondary to adenocarcinoma of the breast: a cadaveric case report. Cureus. 2021;13
Zima LA, Tulpule S, Samson K, Shonka N. Seizure prevalence, contributing factors, and prognostic factors in patients with leptomeningeal disease. J Neurol Sci. 2019;403:19–23.
Siegal T, Mildworf B, Stein D, Melamed E. Leptomeningeal metastases: reduction in regional cerebral blood flow and cognitive impairment. Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc. 1985;17:100–2.
Batool A, & Kasi A. Leptomeningeal Carcinomatosis. in StatPearls [Internet] (StatPearls Publishing, 2021)
Sekhar A, Corbo B, Das K, Biswas S. Leptomeningeal carcinomatosis: easy to miss. J Royal College Phys Edinburgh. 2017;47:351–2.
Gutiérrez ML, Carrasco-Moro R, Ruz-Caracuel I & San Millán JSM. Stroke secondary to leptomeningeal carcinomatosis with radiologic signs of arterial invasion. Surg Neurol Int. 2022;13
Trivedi R, Nichols P, Coley S, Cadoux-Hudson T, Donaghy M. Leptomeningeal glioblastoma presenting with multiple cranial neuropathies and confusion. Clin Neurol Neurosurg. 2000;102:223–6.
Article CAS PubMed Google Scholar
Collie D, et al. Imaging features of leptomeningeal metastases. Clin Radiol. 1999;54:765–71.
Article CAS PubMed Google Scholar
Abrey LE, Chamberlain M, & Engelhard H. Leptomeningeal Metastases, (Springer Science & Business Media, 2006)
Groves MD. Leptomeningeal disease. Neurosurgery. Clinics. 2011;22:67–78.
Herrlinger U, et al. Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci. 2004;223:167–78.
prognostic factors and associated outcomes. Brower, J.V., Saha, S., Rosenberg, S.A., Hullett, C.R. & Ian Robins, H. Management of leptomeningeal metastases. J Clin Neurosci. 2016;27:130–7.
留言 (0)